Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120.
暂无分享,去创建一个
Daniel Malamud | Zhiwei Wu | I. Chaiken | D. Malamud | J. Magnani | D. V. Van Ryk | William R Abrams | W. Abrams | Donald Van Ryk | Irwin Chaiken | Cheryl Davis | John Magnani | C. Davis | Zhiwei Wu
[1] H. Gewurz,et al. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. , 2000, The Journal of general virology.
[2] H. Friedman,et al. Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus. , 1998, The Journal of infectious diseases.
[3] H. Friedman,et al. Human submandibular saliva specifically inhibits HIV type 1. , 1997, AIDS research and human retroviruses.
[4] P. Fox,et al. Saliva inhibits HIV-1 infectivity. , 1988, Journal of the American Dental Association.
[5] A. Trkola,et al. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex , 1997, Journal of virology.
[6] B. Prabhakar,et al. Detection of proviral sequences in saliva of patients infected with human immunodeficiency virus type 1. , 1991, AIDS research and human retroviruses.
[7] D. Malamud,et al. Saliva and inhibition of HIV-1 infection: molecular mechanisms. , 2002, Oral diseases.
[8] D. Malamud,et al. Streptococcal-host interactions. Structural and functional analysis of a Streptococcus sanguis receptor for a human salivary glycoprotein. , 1990, The Journal of biological chemistry.
[9] Rebecca L Rich,et al. Survey of the year 2003 commercial optical biosensor literature , 2005, Journal of molecular recognition : JMR.
[10] K. Baar. The National Movement to Halt the Spread of Multifamily Housing, 1890-1926 , 1992 .
[11] D. Malamud,et al. Differential distribution of salivary agglutinin and amylase in the Golgi apparatus and secretory granules of human salivary gland acinar cells , 1991, The Anatomical record.
[12] R. Silverstein,et al. Identification of a CD36-related Thrombospondin 1–binding Domain in HIV-1 Envelope Glycoprotein gp120: Relationship to HIV-1–specific Inhibitory Factors in Human Saliva , 1998, The Journal of experimental medicine.
[13] Q. Sattentau,et al. Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity , 1998, Journal of Virology.
[14] C. Barr,et al. Recovery of infectious HIV-1 from whole saliva. , 1992, Journal of the American Dental Association.
[15] C. Broder,et al. Calcium ions are required for cell fusion mediated by the CD4-human immunodeficiency virus type 1 envelope glycoprotein interaction , 1993, Journal of virology.
[16] D. Malamud,et al. Comparison of Streptococcus mutans and Streptococcus sanguis receptors for human salivary agglutinin. , 1990, Microbial pathogenesis.
[17] A. Poustka,et al. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. , 2000, Cancer research.
[18] S. Baron,et al. Correlation of nonspecific antiviral activity with the ability to isolate infectious HIV-1 from saliva. , 1994, The New England journal of medicine.
[19] J. Groopman,et al. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus , 1989, The Journal of experimental medicine.
[20] U. Holmskov,et al. Isolation and Characterization of a New Member of the Scavenger Receptor Superfamily, Glycoprotein-340 (gp-340), as a Lung Surfactant Protein-D Binding Molecule* , 1997, The Journal of Biological Chemistry.
[21] P. Luciw,et al. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection , 1997, Journal of virology.
[22] Douglas S Kwon,et al. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.
[23] D. Dripps,et al. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. , 1995, The Journal of clinical investigation.
[24] E. Vigoren,et al. Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity. , 2001, Oral diseases.
[25] J. Rundegren,et al. Characterization of a salivary agglutinin reacting with a serotype c strain of Streptococcus mutans. , 1983, European journal of biochemistry.
[26] R. Lamont,et al. Cloning and expression of a Streptococcus sanguis surface antigen that interacts with a human salivary agglutinin , 1988, Infection and immunity.
[27] D. Shugars. Endogenous mucosal antiviral factors of the oral cavity. , 1999, The Journal of infectious diseases.
[28] Reed J. Harris,et al. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. , 1990, The Journal of biological chemistry.
[29] D. Malamud,et al. gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction. , 2004, AIDS research and human retroviruses.
[30] U. Holmskov,et al. Human salivary agglutinin binds to lung surfactant protein-D and is identical with scavenger receptor protein gp-340. , 2001, The Biochemical journal.
[31] L. Epstein,et al. Interaction of HIV-1 and human salivary mucins. , 1994, Journal of acquired immune deficiency syndromes.
[32] C. Nilsson,et al. Salivary Agglutinin, Which Binds Streptococcus mutansand Helicobacter pylori, Is the Lung Scavenger Receptor Cysteine-rich Protein gp-340* , 2000, The Journal of Biological Chemistry.
[33] M. Rosenberg,et al. The N-terminal 31 amino acids of human immunodeficiency virus type 1 envelope protein gp120 contain a potential gp41 contact site , 1991, Journal of virology.
[34] S. Baron,et al. Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes. , 1999, Archives of internal medicine.
[35] D. Malamud,et al. A MODEL FOR SALIVA-MEDIATED BACTERIAL AGGREGATION , 1981 .
[36] M. Harmsen,et al. Antiviral activities of lactoferrin. , 2001, Antiviral research.
[37] A. Poustka,et al. Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. , 1999, Proceedings of the National Academy of Sciences of the United States of America.